It is well known that glucocorticoids induce peripheral insulin resistance in rodents and humans. Here, we investigated the structural and ultrastructural modifications, as well as the proteins involved in beta-cell function and proliferation, in islets from insulin-resistant rats. Adult male Wistar rats were made insulin resistant by daily administration of dexamethasone (DEX; 1mg/kg, i.p.) for five consecutive days, whilst control (CTL) rats received saline alone. Structure analyses showed a marked hypertrophy of DEX islets with an increase of 1.7-fold in islet mass and of 1.6-fold in islet density compared with CTL islets (P < 0.05). Ultrastructural evaluation of islets revealed an increased amount of secreting organelles, such as endoplasmic reticulum and Golgi apparatus in DEX islets. Mitotic figures were observed in DEX islets at structural and ultrastructural levels. Beta-cell proliferation, evaluated at the immunohistochemical level using anti-PCNA (proliferating cell nuclear antigen), showed an increase in pancreatic beta-cell proliferation of 6.4-fold in DEX islets compared with CTL islets (P < 0.0001). Increases in insulin receptor substrate-2 (IRS-2), phosphorylated-serine-threonine kinase AKT (p-AKT), cyclin D2 and a decrease in retinoblastoma protein (pRb) levels were observed in DEX islets compared with CTL islets (P < 0.05). Therefore, during the development of insulin resistance, the endocrine pancreas adapts itself increasing beta-cell mass and proliferation, resulting in an amelioration of the functions. The potential mechanisms that underlie these events involve the activation of the IRS-2/AKT pathway and activation of the cell cycle, mediated by cyclin D2. These adaptations permit the maintenance of glycaemia at near-physiological ranges. © 2008 The Authors.894264275Alonso, L.C., Yokoe, T., Zhang, P., Glucose infusion in mice. a new model to induce β-cell replication (2007) Diabetes, 56, pp. 1792-1801Amaral, M.E., Cunha, D.A., Anhê, G.F., Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy (2004) J. Endocrinol., 183, pp. 469-476Anderson, J.W., Kendall, C.W., Jenkins, D.J., Importance of weight management in type 2 diabetes: Review with meta-analysis of clinical studies (2003) J. Am. Coll. Nutr., 22, pp. 331-339Araki, E., Lipes, M.A., Patti, M.E., Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene (1994) Nature, 372, pp. 186-190Barbera, M., Fierabracci, V., Novelli, M., Dexamethasone-induced insulin resistance and pancreatic adaptive response in aging rats are not modified by oral vanadyl sulfate treatment (2001) Eur. J. Endocrinol., 145, pp. 799-806Beard, J.C., Halter, J.B., Best, J.D., Pfeifer, M.A., Porte Jr., D., Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men (1984) Am. J. Physiol., 247, pp. E592-E596Bonner-Weir, S., Life and death of the pancreatic beta cells (2000) Trends Endocrinol. Metab., 11, pp. 375-378Bonner-Weir, S., Beta-cell turnover: Its assessment and implications (2001) Diabetes, 50, pp. S20-S24Bonner-Weir, S., Trent, D.F., Zmachinski, C.J., Clore, E.T., Weir, G.C., Limited B cell regeneration in a B cell deficient rat model: Studies with dexamethasone (1981) Metabolism, 9, pp. 914-918Boquist, L., Obesity and pancreatic islet hyperplasia in the Mongolian gerbil (1972) Diabetologia, 8, pp. 274-282Bruning, J.C., Winnay, J., Bonner-Weir, S., Taylor, S.I., Accili, D., Kahn, C.R., Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles (1997) Cell, 88, pp. 561-572Burén, J., Liu, H.X., Jensen, J., Eriksson, J.W., Dexamethasone impairs insulin signaling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes (2002) Eur. J. Endocrinol., 146, pp. 419-429Cotta-Pereira, G., Rodrigo, F.G., David-Ferreira, J.F., The use of tannic acid-glutaraldehyde in the study of elastic related fibers (1976) Stain Technol., 51, pp. 7-11Cozar-Castellano, I., Takane, K.K., Bottino, R., Balamurugan, A.N., Stewart, A.F., Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and in human islet using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1 (2004) Diabetes, 53, pp. 149-159De Carvalho, H.F., Lino Neto, J., Taboga, S.R., Microfibrils: Neglected components of pressure-bearing tendons (1994) Ann. Anat., 176, pp. 155-159Diani, A.R., Sawada, G.A., Hannah, B.A., Analysis of pancreatic islet cells and hormone content in the spontaneously diabetic KKAy mouse by morphometry, immunocytochemistry and radioimmunoassay (1987) Virch. Arch. A. Pathol. Anat. Histopathol., 412, pp. 53-61Fatrai, S., Elghazi, L., Balcazar, N., AKT induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity (2006) Diabetes, 55, pp. 318-325Fernández, E., Angeles Mártin, M., Fajardo, S., Escrivá, F., Álvarez, C., Increased IRS-2 content and activation of IGF-1 pathway contribute to enhance B-cell mass in fetuses from undernourished pregnant rats (2006) Am. J. Physiol. Endocrinol. Metab., 292, pp. E187-E195Friedrichsen, B.N., Neubauer, N., Lee, Y.C., Stimulation of pancreatic β-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways (2006) J. Endocrinol., 188, pp. 481-492Garcia-Ocaña, A., Takane, K., Syed, M.A., Phlibrick, W.M., Vasavada, R.C., Stewart, A.F., Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass and induces mild hypoglycemia (2000) J. Biol. Chem., 275, pp. 1226-1232Gómez Dumm, C.L.A., Cónsole, M., Luna, G.C., Dardene, M., Goya, R.G., Quantitative immunohistochemical changes in the endocrine pancreas of nonobese diabetic (NOD) mice (1995) Pancreas, 11, pp. 396-401Heit, J.J., Karnik, S.K., Kim, S.K., Intrinsic regulators of pancreatic β-cell proliferation (2006) Ann. Rev. Cell. Dev. Biol., 22, pp. 311-338Holness, M.J., Smith, N.D., Greenwood, G.K., Sugden, M.C., Interactive influences of peroxisome proliferator-activated receptor α activation and glucocorticoids on pancreatic beta cell compensation in insulin resistance induced by dietary saturated fat in the rat (2005) Diabetologia, 48, pp. 2062-2068Hoogwerf, B., Danese, R.D., Drug selection and the management of corticosteroid-related diabetes mellitus (1999) Rheum. Dis. Clin. North Am., 25, pp. 489-505Janssen, S.W., Hermus, A.R., Lange, W.P., Progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats (2001) Exp. Clin. Endocrinol. Diabetes, 109, pp. 273-282Janssen, S.W., Martens, G.J., Sweep, C.G., Span, P.N., Verhofstad, A.A., Hermus, A.R., Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during age of Zucker diabetic fatty rats (2003) J. Endocrinol. Invest., 26, pp. 508-515Jonas, L., Putzke, H.P., Hahn Von Dorsche, H., Islands of Langerhans of rats (Rattus norvegicus, Forma alba) after high prednisolone dosage - A semiquantitative light and electron microscopic study (1983) Anat. Anz., 154, pp. 273-282Kido, Y., Burks, D.J., Withers, D., Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2 (2000) J. Clin. Invest., 105, pp. 199-205Kushner, J.A., Ye, J., Schubert, M., Pdx1 restores β cell function in Irs2 knockout mice (2002) J. Clin. Invest., 109, pp. 1193-1201Lingohr, M.K., Dickson, L.M., McCuaig, J.F., Hugl, S.R., Twardzik, D.R., Rhodes, C.J., Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation (2002) Diabetes, 51, pp. 966-976Lipsett, M.A., Austin, E.B., Castellarin, M.L., Lemay, J., Rosenberg, L., Evidence for the homeostatic regulation of induced beta cell mass expansion (2006) Diabetologia, 49, pp. 2910-2919Mello, M.L.S., Cytochemistry of DNA, RNA and nuclear proteins (1997) Braz. J. Genet., 20, pp. 257-264Momose, K., Nunomiya, S., Nakata, M., Yada, T., Kikuchi, M., Yashiro, T., Immunohistochemical and electron-microscopic observation of B-cells in pancreatic islets of spontaneously diabetic Goto-Kakizaki rats (2006) Med. Mol. Morphol., 39, pp. 146-153Muller, D., Jones, P.M., Persaud, S.J., Autocrine anti-apoptotic and proliferative effects of insulin in pancreatic b-cells (2006) FEBS Lett., 580, pp. 6977-6980Nicod, N., Giusti, V., Besse, C., Tappy, L., Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers (2003) Obes. Res., 11, pp. 625-631Niessen, A., On the role of IRS2 in the regulation of functional ß-cell mass (2006) Arch. Physiol. Biochem., 112, pp. 65-73Novelli, M., De Tata, V., Bombara, M., Insufficient adaptive capability of pancreatic endocrine function in dexamethasone-treated ageing rats (1999) J. Endocrinol., 162, pp. 425-432Ogawa, A., Johnson, J.H., Ohneda, M., Roles of insulin resistance and ß-cell dysfunction in dexamethasone-induced diabetes (1992) J. Clin. Invest., 90, pp. 497-504Okada, T., Liew, C.W., Hu, J., Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance (2007) Proc. Natl Acad. Sci. USA, 104, pp. 8977-8982Pagano, G., Cavallo-Perin, P., Cassader, M., An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects (1983) J. Clin. Invest., 72, pp. 1814-1820Paris, M., Bernard-Kargar, C., Berthault, M.F., Bouwens, L., Ktorza, A., Specific and combined effects of insulin and glucose on functional pancreatic β-cell mass in vivo in adult rats (2003) Endocrinology, 144, pp. 2717-2727Pick, A., Clark, J., Kubstrup, C., Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat (1998) Diabetes, 47, pp. 358-364Rafacho, A., Roma, L.P., Taboga, S.R., Boschero, A.C., Bosqueiro, J.R., Dexamethasone-induced insulin resistance is associated with increased connexins 36 mRNA and protein expression in pancreatic rat islets (2007) Can. J. Physiol. Pharmacol., 53, pp. 881-885Rafacho, A., Giozzet, V.A.G., Boschero, A.C., Bosqueiro, J.R., Functional alterations in endocrine pancreas of rats with different degrees of dexamethasone-induced insulin resistance (2008) Pancreas, 36, pp. 284-293Ruzzin, J., Wagman, A.S., Jensen, J., Glucocorticoid-induced insulin resistance in skeletal muscles: Defects in insulin signaling and the effects of a selective glycogen synthase kinase-3 inhibitor (2005) Diabetologia, 48, pp. 2119-2130Saad, M.J., Folli, F., Kahn, J.A., Kahn, C.R., Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats (1993) J. Clin. Invest., 92, pp. 2065-2072Scott, A.M., Atwater, I., Rojas, E., A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans (1981) Diabetologia, 21, pp. 470-475Severino, C., Brizzi, P., Solinas, A., Secchi, G., Maioli, M., Tonolo, G., Low-dose dexamethasone in the rat. a model to study insulin resistance (2002) Am. J. Physiol., 283, pp. E367-E373Spencer, A.J., Andreu, M., Greaves, P., Neoplasia and hyperplasia of pancreatic endocrine tissue in the rat: An immunocytochemical study (1986) Vet. Pathol., 23, pp. 11-15Tamemoto, H., Kadowaki, T., Tobe, K., Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 (1994) Nature, 372, pp. 182-186Terauchi, I., Takamoto, I., Kubota, N., Glucokinase and IRS-2 are required for compensatory B cell hyperplasia in response to high-fat diet-induced insulin resistance (2007) J. Clin. Invest., 117, pp. 246-257Tomita, T., Visser, P., Friesen, S., Doull, V., Cortisone-induced islet cell hyperplasia in hamsters (1984) Virch. Arch. B Cell Pathol. Incl. Mol. Pathol., 45, pp. 85-95Vasavada, R.C., Gonzáles-Pertusa, J.A., Fujinaka, I., Fiaschi-Taesch, N., Cozar-Castellano, I., Garcia-Ocaña, A., Growth factors and beta cell replication (2006) Int. J. Biochem. Cell Biol., 38, pp. 931-950Vasavada, R.C., Cozar-Castellano, I., Sipula, D., Stewart, A.F., Tissue-specific deletion of the retinoblastoma protein in the pancreatic B-cell has limited effects on B-cell replication, mass, and function (2007) Diabetes, 56, pp. 57-64Villanueva-Peñacarrillo, M.L., Cancelas, J., De Miguel, F., Parathyroid hormone-related peptide stimulates DNA synthesis and insulin secretion in pancreatic islets (1999) J. Endocrinol., 163, pp. 403-408Visser, P.A., Pierce, G.E., Tomita, T., Friesen, S.R., Stimulation of pancreatic islet hypertrophy and beta-cell hyperplasia in Syrian hamsters (1979) Surg. Forum, 30, pp. 310-311Weibel, E.R., The value of stereology in analysing structure and function of cells and organs (1972) J. Microsc., 95, pp. 3-13Weir, G.C., Laybutt, D.R., Kaneto, H., Bonner-Weir, S., Sharma, A., Beta-cell adaptation and decompensation during the progression of diabetes (2001) Diabetes, 50, pp. S154-S159Withers, D.J., Gutierrez, J.S., Towery, H., Burks, D.J., Ren, J.M., Disruption of IRS-2 causes type 2 diabetes in mice (1998) Nature, 391, pp. 900-904Zhang, X., Gaspard, J.P., Mizukami, Y., Li, J., Graeme-Cook, F., Chung, D.C., Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia (2005) Diabetes, 54, pp. 712-719Zwicker, G.M., Eyster, R.C., Chronic effects of corticosteroid oral treatment in rats on blood glucose and serum insulin levels, pancreatic islet morphology, and immunostaining characteristics (1993) Toxicol. Pathol., 21, pp. 502-508